Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells (2024) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Aigner M, Völkl S, et al. Journal article CAR T-cell perspectives in lupus – Authors' reply (2024) Schett G, Mackensen A, Mougiakakos D Journal article 177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study (2024) Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel ME, Kunz PL, Chasen B, et al. Journal article Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study (2024) Chan K, Wahome E, Tsiachristas A, Antonopoulos AS, Patel P, Lyasheva M, Kingham L, et al. Journal article Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial (2024) Beck J, Fung C, Strbian D, Bütikofer L, Z'Graggen WJ, Lang MF, Beyeler S, et al. Journal article CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis (2024) Krickau T, Naumann-Bartsch N, Aigner M, Kharboutli S, Kretschmann S, Spörl S, Vasova I, et al. Journal article Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial (2024) Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schönau V, Hueber A, et al. Journal article Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials. (2024) Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, et al. Journal article Adult epilepsy (2023) Asadi-Pooya AA, Brigo F, Lattanzi S, Blümcke I Journal article, Review article CD19-targeted CAR T cells in refractory antisynthetase syndrome (2023) Müller F, Böltz S, Knitza J, Aigner M, Völkl S, Kharboutli S, Reimann H, et al. Journal article